Twitter Facebook LinkedIn YouTube

Khiron Life Sciences Corp. (TSXV:KHRN) New Listing

Video Platform Video Management Video Solutions Video Player

Khiron is a Canadian integrated medical cannabis product development company with its core operations in Colombia, South America.

Additional Information:

Company: Khiron Life Sciences Corp.
Website: http://www.khiron.ca
Stock Symbol: TSXV: KHRN
Date Published: May 24, 2018
Transcript: Available

Video Transcript:

I’m Megan Edwards for Investmentpitch Media

Khiron Life Sciences Corp. is the latest new listing on the TSX Venture Exchange, trading under the symbol “KHRN”, following its Qualifying Transaction with Capital Pool company “Adent Capital”.

Khiron is a Canadian integrated medical cannabis product development company with its core operations
in Colombia, South America.

In September and October 2017, through its Colombian subsidiary, the company received all necessary approvals to cultivate, produce, distribute domestically and export internationally both high and low THC extracts and CBD medicinal cannabis.

The company has an installed capacity of 8,000 kilograms per year with 7,500 square meters of cultivated area in Phase I, located in an established agricultural region just a three hour drive from Bogota.

The company’s primary focus is to sell medicinal cannabis products in the form of extracts to the domestic market in Colombia, a country with a population of 48.6 million people.

It plans on addressing the unmet medicinal cannabis needs of prospective Colombian patients with conditions including chronic pain, depression, anxiety and other conditions.

The company combines leading international scientific expertise with branded product market entrance experience, and is well positioned to continue its expansion to address the unmet medical needs of over 620 million people in the Latin American market.

The company is well financed having recently raised gross proceeds of $11,230,000 through a private placement of 11,230,000 units priced at $1.00 per unit.

Each unit consisted of 1 share and 1 warrant, with each warrant exercisable at $1.20 for 24 months.

The private placement was led by Canaccord Genuity Corp. as the Lead Agent, along with Eight Capital.

The shares are trading at $1.19.

For more information, please visit the company’s website www.khiron.ca, contact Darren Collins, CFO, at 705-527-3564 or email dcollins@khiron.ca.

I’m Megan Edwards for Investmentpitch Media